Show an ad over header. AMP

Why tech couldn't save us from COVID

Tech's biggest, richest companies haveproved powerless to help stop or stem the pandemic — largely because the companies' own products have destabilized the public sphere.

The big picture: When the greatest public health disaster of our lifetimes hit, the industry, despite earnest efforts, found that the information environment it had shaped via the internet and social media was profoundly vulnerable to misinformation, partisan division, ignorance and fraud.

  • In that environment, tech could generate all the innovative quick-fixes and agile solutions that it specializes in, but they would never have a chance.
  • No one expects tech companies to develop vaccines or promulgate quarantine policy on their own, but in a crisis U.S. political and business leaders today turn to the tech industry for resources, innovations and problem-solving muscle.

Flashback: Silicon Valley saw the crisis as a moment to shine.

  • It provided an opportunity to reverse years of negative publicity around data privacy, misinformation and hate speech, and charges of anti-competitive practices — and to apply its engineering prowess to a collective threat.
  • During the first wave of lockdowns in the U.S. in March and April, the tech industry, moving into a leadership vacuum left by the federal government, mobilized to enable remote work and schooling and began building systems for virus tracking.
  • "The government has flailed in its response to the pandemic, and Big Tech has presented itself as a beneficent friend, willing to lend a competent hand," as Franklin Foer wrote in The Atlantic.

Tech was among the very first business sectors to shut down big events and send workers home.

But the pandemic itself became a slowly cascading train wreck in the U.S. that shows no signs of ending. It has already left nearly 200,000 dead and put the economy in a coma.

Be smart: You can thoughtfully design contact-tracing tech to protect individual privacy and generate useful data. None of that will matter if the public — distracted by conspiracy theories, partisan propaganda and discredit-the-experts campaigns,all amplified by ill-defended platforms — doesn't believe contact tracing is needed or distrusts the institutions behind it.

The industry's failures fall into three categories:

(1) Data distrust. Tech's mindset is data-driven, and the public health field traditionally works behind a "politics ends here" cordon.

  • But coronavirus data became a partisan flashpoint early on, as the Trump administration — fueled by a populist resentment of experts — sought to downplay the pandemic's impact.
  • Even as Silicon Valley thought leaders set up smart visualizations of real-time virus data, the president and his supporters were using the industry's own platforms to challenge the validity of the numbers.

(2) The limits of incrementalism. Tech's preference is to break big, "hairy" projects down into small pieces and tackle those fast with "minimum viable products."

  • That's a great roadmap for tackling daunting technical challenges or taking the first steps toward a moon shot.
  • It doesn't work well with a problem like the pandemic, with its tangle of "human factors" and social complexities that don't cleave easily.

(3) The consensus-building blind spot. Public health campaigns depend on building trust across social, economic and geographical divides to persuade people to follow medical recommendations or get vaccinated.

  • The social media universe built by Silicon Valley, with its libertarian-individualist roots, efficiently breaks the public down into targetable chunks and amplifies divisive voices.
  • It's never been good at bringing people together or helping form a consensus.

Our thought bubble: Everything that tech could do to help mitigate the pandemic — and there was plenty — depended on the presence of strong national leadership committed to a fact-based response to the crisis.

  • When the Trump administration instead chose a response that questioned science, politicized public-health controversies and left each state to chart its own course, the tech industry had no plan B.

The bottom line: The tech industry, buffered by enormous cash reserves and record new levels of user demand, has used the long coronavirus siege to bet big on acquisitions and risky new investments.

  • But for tech CEOs and employees still motivated by the call to make the world a better place, the pandemic has been a humbling demonstration of their systems' inadequacies and limitations.

Biden: The next president should decide on Ginsburg’s replacement

Joe Biden is calling for the winner of November's presidential election to select Ruth Bader Ginsburg's replacement on the Supreme Court.

What he's saying: "[L]et me be clear: The voters should pick the president and the president should pick the justice for the Senate to consider," Biden said. "This was the position the Republican Senate took in 2016 when there were almost 10 months to go before the election. That's the position the United States Senate must take today, and the election's only 46 days off.

Keep reading... Show less

Biden: "Ruth Bader Ginsburg stood for the law"

Joe Biden said Supreme Court Justice Ruth Bader Ginsburg "never failed, she was fierce and unflinching in her pursuit of civil and legal right and civil rights of everyone," after learning of her death Friday night.

What he's saying: Biden gave a statement after traveling to Delaware from Minnesota, where, earlier Friday, he gave a campaign speech at a carpenters’ training center in Hermantown, a suburb of Duluth. She was "not only a giant in the legal profession, but a beloved figure, and my heart goes out to all those who cared for her and cared about her."

Keep reading... Show less

Trump: Ruth Bader Ginsburg "led an amazing life"

President Trump said Supreme Court Justice Ruth Bader Ginsburg "led an amazing life," after he finished a campaign rally in Bemidji, Minnesota, and learned of her death.

What he's saying: "I’m sad to hear,” Trump told the press pool before boarding Air Force One. "She was an amazing woman, whether you agree or not, she was an amazing woman who led an amazing life."

Keep reading... Show less

Trump to move fast to replace Supreme Court Justice Ruth Bader Ginsburg

President Trump will move within days to nominate his third Supreme Court justice in just three-plus short years — and shape the court for literally decades to come, top Republican sources tell Axios.

Driving the news: Senate Majority Leader Mitch McConnell and Senate Republicans are ready to move to confirm Trump's nominee before Election Day, just 46 days away, setting up one of the most consequential periods of our lifetimes, the sources say.

Keep reading... Show less

What they're saying: Ruth Bader Ginsburg was a "tireless and resolute champion of justice"

Democratic and Republican lawmakers along with other leading figures paid tribute to Supreme Court Justice Ruth Bader Ginsburg, who died on Friday night at age 87.

What they're saying: “Our Nation has lost a jurist of historic stature," Chief Justice John Roberts said. "We at the Supreme Court have lost a cherished colleague. Today we mourn, but with confidence that future generations will remember Ruth Bader Ginsburg as we knew her — a tireless and resolute champion of justice.”

Keep reading... Show less

Supreme Court Justice Ruth Bader Ginsburg dies at 87

Supreme Court Justice Ruth Bader Ginsburg has died at 87.

Why it matters: Ginsburg had suffered from serious health issues over the past few years, including cancer. Her death sets up a fight over filling a Supreme Court seat with less than 50 days until the election.

Keep reading... Show less

NYT: White House drug price negotiations between broke down over $100 "Trump Cards"

Negotiations on a deal between the White House and pharmaceutical industry to lower drug prices broke down last month after Mark Meadows, the president's chief of staff, insisted that drugmakers pay for $100 cash cards to be mailed to seniors before the election, according to the New York Times.

Why it matters: Some of the drug companies feared that in agreeing to the prescription cards — reportedly dubbed "Trump Cards" by some in the pharmaceutical industry — they would boost Trump's political standing weeks ahead of Election Day with voters over 65, a group that is crucial to the president's reelection bid, per the Times.

Keep reading... Show less

In photos: Virginians line up for hours on first day of early voting

In some parts of Virginia, people waited in line up to four hours to cast their ballots on the first day of early voting, according to the Washington Post.

The big picture: The COVID-19 pandemic seems to already have an impact on how people cast their votes this election season. As many as 80 million Americans are expected to vote early, by mail or in person, Tom Bonier, CEO of TargetSmart, a Democratic political data firm, told Axios in August.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories